top
Search terms
Results 1 - 10 of 459 - ordered by :
Pages: 1 2 3 4 5 6 7 ... 46
Epeuropace

6.1.4.1 Heart failure with reduced left ventricular ejection fraction and New York Heart Association class III/ambulatory class IV Table A. Cardiac resynchronization therapy in the primary prevention ...

Europace, ESC GUIDELINES, Authors/Task Force Members, Silvia G. Priori, Carina Blomström-Lundqvist, Andrea Mazzanti, Nico Blom, Martin Borggrefe, John Camm, Perry Mark Elliott, Donna Fitzsimons, ...

Date : 01/11/2015 Item size : 3637853 bytes
Epeuropace

Abstract Introduction Paraseptal pathways, namely, accessory connections (AC) in the vicinity of the atrioventricular node (AVN) and the bundle of His, are associated with a high risk of complete ...

Europace, Review, Konstantinos Gatzoulis, Theodoros Apostolopoulos, Xenofon Costeas, Hlias Sotiropoulos, Fanis Papafanis, Christodoulos Stefanadis, Pavlos Toutouzas

Date : 01/01/2004 Item size : 194948 bytes
Epeuropace

Abstract With an ageing population, atrial fibrillation has become an increasing cause of hospital admission and morbidity. There are clearly some patients who benefit from implantation of these ...

Europace, Review, Andrew R.J. Mitchell, Neil Sulke

Date : 01/01/2004 Item size : 244006 bytes
Epeuropace

Ventricular tachycardia (VT) is a common complication in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVD). Implantable cardioverter defibrillator (ICD) therapy provides ...

Europace, Articles, Hielko Miljoen, Simona State, Christian de Chillou, Isabelle Magnin-Poull, Pierre Dotto, Marius Andronache, Ahmed Abdelaal, Etienne Aliot

Date : 01/11/2005 Item size : 215396 bytes
Epeuropace

Abstract Aims We assessed responses to slow pathway ablation with respect to the appearance of ventriculoatrial (VA) block during junctional rhythm in both typical and atypical types of ...

Europace, Electrophysiology/ablation, Akira Fujiki, Tamotsu Sakamoto, Masao Sakabe, Takayuki Tsuneda, Masataka Sugao, Yosuke Nakatani, Koichi Mizumaki, Hiroshi Inoue

Date : 01/08/2008 Item size : 194973 bytes
Epeuropace

Treatments with angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, statins, and omega-3 fatty acids all seem promising, over and above any effect related to the treatment of ...

Europace, ATRIAL FIBRILLATION, Irina Savelieva, John Camm

Date : 01/06/2008 Item size : 547475 bytes
Epeuropace

Antiarrhythmic drug administration is the first-line therapy, but Class I antiarrhythmic drugs often fail to maintain sinus rhythm and may worsen heart failure.1 Amiodarone is more effective, but ...

Europace, Electrophysiology and ablation, Meiso Hayashi, Yasushi Miyauchi, Hiroshige Murata, Kenta Takahashi, Ippei Tsuboi, Shunsuke Uetake, Hiroshi Hayashi, Tsutomu Horie, Kenji Yodogawa, Yu-ki ...

Date : 01/01/2014 Item size : 240960 bytes
Epeuropace

Introduction Atrial fibrillation (AF) has a progressive nature.14 It has been increasingly recognized that there is a tendency for AF to become sustained over time and more resistant to cardioversion ...

Europace, CLINICAL RESEARCH, Eleftherios M. Kallergis, Christos A. Goudis, Emmanuel M. Kanoupakis, Hercules E. Mavrakis, Niki E. Maliaraki, Nikos Tzanakis, Panos E. Vardas

Date : 01/12/2014 Item size : 188440 bytes
Epeuropace

While familial forms had remained mostly unknown, in this last decade, the identification of genetic defects, which mainly affect ionic currents, has been the key in our understanding of the ...

Europace, Review, Oscar Campuzano, Ramon Brugada

Date : 01/10/2009 Item size : 256585 bytes
Epeuropace

Abstract Aims The purpose of our study was to determine the acute effects of complex fractionated electrograms (CFAE) ablation guided by automated detection on dominant frequency (DF) and regulatory ...

Europace, CLINICAL RESEARCH, Gabor Bencsik, Martin Martinek, Said Hassanein, Josef Aichinger, Hans-Joachim Nesser, Helmut Purerfellner

Date : 01/08/2009 Item size : 251948 bytes